首页 > 最新文献

Surgery for Obesity and Related Diseases最新文献

英文 中文
American Society for Metabolic and Bariatric Surgery review of endobariatric procedures 美国代谢和减肥外科学会对减肥手术的回顾。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.10.001
Salvatore Docimo Jr. D.O., M.B.A. , Rodolfo J. Oviedo M.D. , Cheguevara Afaneh M.D. , Bruce Schirmer M.D. , Fady Moustarah M.D. , Karen Grothe Ph.D. , R.Wesley Vosburg M.D. , Jonathan Carter M.D. , Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery

Background

Endoscopic bariatrics is a growing area of interest in the battle against obesity. This systematic review provides a review of the pertinent endoluminal approaches to bariatrics. The purpose of this review is to describe the current indications, clinical outcomes, safety profile, and the progress of endoluminal bariatric therapies for both primary and revisional indications.

Methods

We conducted a systematic review based on the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). A review of databases were performed and all studies were then evaluated based on inclusion and exclusion criteria: all studies with participants over the age of 18 years, a meta-analysis design, a randomized trial design, or a cohort study design were included. All case reports, letters, comments, and animal and in vitro studies were excluded.

Results

A total of 9586 articles were retrieved from our search. After removing duplicates, 7778 studies remained. After applying inclusion and exclusion criteria, and adding one study from our review of citations, a total of 46 studies were included in our study (Fig. 1).

Discussion

This review was conducted utilizing all aspects of the PRISMA model for systematic review. The 46 studies included summaries the various approaches to endoluminal bariatrics and provides a thorough overview of outcomes and complications.
背景:内窥镜减肥术是对抗肥胖的一个越来越受关注的领域。这篇系统的综述综述了相关的腹腔内减肥方法。本综述的目的是描述目前的适应症、临床结果、安全性以及针对主要和修正适应症的肠内减肥治疗的进展。方法:我们根据系统评价和荟萃分析首选报告项目(PRISMA)的指南进行了系统评价。对数据库进行回顾,然后根据纳入和排除标准对所有研究进行评估:包括所有参与者年龄在18岁以上的研究、荟萃分析设计、随机试验设计或队列研究设计。所有病例报告、信件、评论以及动物和体外研究均被排除在外。结果:共检索到9586篇文献。剔除重复项后,还剩下7778项研究。应用纳入和排除标准,并从我们的文献综述中增加一项研究,我们的研究共纳入46项研究(图1)。讨论:本综述利用PRISMA模型的各个方面进行系统评价。这46项研究总结了不同的肠内减肥方法,并提供了结果和并发症的全面概述。
{"title":"American Society for Metabolic and Bariatric Surgery review of endobariatric procedures","authors":"Salvatore Docimo Jr. D.O., M.B.A. ,&nbsp;Rodolfo J. Oviedo M.D. ,&nbsp;Cheguevara Afaneh M.D. ,&nbsp;Bruce Schirmer M.D. ,&nbsp;Fady Moustarah M.D. ,&nbsp;Karen Grothe Ph.D. ,&nbsp;R.Wesley Vosburg M.D. ,&nbsp;Jonathan Carter M.D. ,&nbsp;Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery","doi":"10.1016/j.soard.2025.10.001","DOIUrl":"10.1016/j.soard.2025.10.001","url":null,"abstract":"<div><h3>Background</h3><div>Endoscopic bariatrics is a growing area of interest in the battle against obesity. This systematic review provides a review of the pertinent endoluminal approaches to bariatrics. The purpose of this review is to describe the current indications, clinical outcomes, safety profile, and the progress of endoluminal bariatric therapies for both primary and revisional indications.</div></div><div><h3>Methods</h3><div>We conducted a systematic review based on the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). A review of databases were performed and all studies were then evaluated based on inclusion and exclusion criteria: all studies with participants over the age of 18 years, a meta-analysis design, a randomized trial design, or a cohort study design were included. All case reports, letters, comments, and animal and in vitro studies were excluded.</div></div><div><h3>Results</h3><div>A total of 9586 articles were retrieved from our search. After removing duplicates, 7778 studies remained. After applying inclusion and exclusion criteria, and adding one study from our review of citations, a total of 46 studies were included in our study (Fig. 1).</div></div><div><h3>Discussion</h3><div>This review was conducted utilizing all aspects of the PRISMA model for systematic review. The 46 studies included summaries the various approaches to endoluminal bariatrics and provides a thorough overview of outcomes and complications.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 1-17"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145508744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: kidney transplantation after bariatric surgery – outcomes from a 30-year experience 评论:30年经验的减肥手术后肾移植。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.11.014
Nicole L. Petcka M.D., Elizabeth M. Hechenbleikner M.D.
{"title":"Comment on: kidney transplantation after bariatric surgery – outcomes from a 30-year experience","authors":"Nicole L. Petcka M.D.,&nbsp;Elizabeth M. Hechenbleikner M.D.","doi":"10.1016/j.soard.2025.11.014","DOIUrl":"10.1016/j.soard.2025.11.014","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 65-66"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145663173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pragmatic strategy for vitamin and micronutrient supplementation after metabolic and bariatric surgery 代谢和减肥手术后维生素和微量营养素补充的实用策略。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.08.023
Hélène Chappard M.D. , Ouidad Sami M.D. , Imen Sakka M.D. , Suzette Coelho , Thierry Dupré M.D. , Muriel Coupaye M.D. , David Moszkowicz M.D., Ph.D. , Séverine Ledoux M.D., Ph.D.

Background

Nutritional deficiencies are frequent after metabolic and bariatric surgery (MBS) and systematic addition of vitamin B12, iron, calcium, and vitamin D to standard multivitamin tablets is recommended. However, there are still uncertainties because supporting data are few and compliance with a large number of tablets is low.

Objectives

To assess the need for additional supplements using a supplementation based on biological assays after Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).

Methods

Consecutive patients (N = 313: 179 RYGB/134 SG; 86% women, mean age 44.1 ± 10.3 years, Body mass index 43.5 ± 6.6 kg/m2) who underwent a nutritional assessment, before and at 6, 12, and 36 months after MBS, were studied. Multivitamin tablets were systematically prescribed after MBS, and additional supplements were introduced following a standardized protocol in the case of deficiency.

Setting

University Hospital, France.

Results

Although the number of patients taking additional supplements increased by more after RYGB than after SG (58.7% vs 43.3%, P < .01), the mean number of deficits did not increase and was similar at 3 years (3.7 vs 3.4, Ns). The frequency of nutritional symptoms was also similar after both procedures, the most common being hair loss, while neurological symptoms were unusual and mild. Anemia was infrequent, but secondary hyperparathyroidism was frequent after RYGB (23% vs 9% after SG, P < .01).

Conclusions

A personalized supplementation strategy adapted to biological parameters, in patients followed regularly up to 3 years after MBS, may reduce the number of nutritional supplements without increasing the number of deficiencies. However, vigilance must be maintained, particularly regarding bone and neurological risks.
背景:代谢和减肥手术(MBS)后经常出现营养缺乏,建议在标准复合维生素片中系统添加维生素B12、铁、钙和维生素D。然而,由于支持数据很少,并且大量平板电脑的依从性很低,因此仍然存在不确定性。目的:评估Roux-en-Y胃旁路(RYGB)和袖式胃切除术(SG)后使用基于生物测定的补充物的额外补充的必要性。方法:研究连续患者(N = 313: 179 RYGB/134 SG; 86%女性,平均年龄44.1±10.3岁,体重指数43.5±6.6 kg/m2),在MBS之前和6、12和36个月后进行营养评估。在MBS后系统地开了复合维生素片,在缺乏的情况下,根据标准化的方案引入了额外的补充剂。地点:法国大学医院。结果:尽管RYGB后服用额外补充剂的患者数量比SG后增加更多(58.7% vs 43.3%, P < 0.01),但平均缺陷数没有增加,并且在3年内相似(3.7 vs 3.4, Ns)。两种手术后出现营养症状的频率也相似,最常见的是脱发,而神经症状不寻常且轻微。贫血不常见,但RYGB术后继发性甲状旁腺功能亢进发生率较高(23% vs 9%, P < 0.01)。结论:在MBS后定期随访3年的患者中,适应生物学参数的个性化补充策略可能会减少营养补充的数量,而不会增加缺乏症的数量。然而,必须保持警惕,特别是对骨骼和神经系统的风险。
{"title":"Pragmatic strategy for vitamin and micronutrient supplementation after metabolic and bariatric surgery","authors":"Hélène Chappard M.D. ,&nbsp;Ouidad Sami M.D. ,&nbsp;Imen Sakka M.D. ,&nbsp;Suzette Coelho ,&nbsp;Thierry Dupré M.D. ,&nbsp;Muriel Coupaye M.D. ,&nbsp;David Moszkowicz M.D., Ph.D. ,&nbsp;Séverine Ledoux M.D., Ph.D.","doi":"10.1016/j.soard.2025.08.023","DOIUrl":"10.1016/j.soard.2025.08.023","url":null,"abstract":"<div><h3>Background</h3><div>Nutritional deficiencies are frequent after metabolic and bariatric surgery (MBS) and systematic addition of vitamin B12, iron, calcium, and vitamin D to standard multivitamin tablets is recommended. However, there are still uncertainties because supporting data are few and compliance with a large number of tablets is low.</div></div><div><h3>Objectives</h3><div>To assess the need for additional supplements using a supplementation based on biological assays after Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).</div></div><div><h3>Methods</h3><div>Consecutive patients (N = 313: 179 RYGB/134 SG; 86% women, mean age 44.1 ± 10.3 years, Body mass index 43.5 ± 6.6 kg/m<sup>2</sup>) who underwent a nutritional assessment, before and at 6, 12, and 36 months after MBS, were studied. Multivitamin tablets were systematically prescribed after MBS, and additional supplements were introduced following a standardized protocol in the case of deficiency.</div></div><div><h3>Setting</h3><div>University Hospital, France.</div></div><div><h3>Results</h3><div>Although the number of patients taking additional supplements increased by more after RYGB than after SG (58.7% vs 43.3%, <em>P</em> &lt; .01), the mean number of deficits did not increase and was similar at 3 years (3.7 vs 3.4, Ns). The frequency of nutritional symptoms was also similar after both procedures, the most common being hair loss, while neurological symptoms were unusual and mild. Anemia was infrequent, but secondary hyperparathyroidism was frequent after RYGB (23% vs 9% after SG, <em>P</em> &lt; .01).</div></div><div><h3>Conclusions</h3><div>A personalized supplementation strategy adapted to biological parameters, in patients followed regularly up to 3 years after MBS, may reduce the number of nutritional supplements without increasing the number of deficiencies. However, vigilance must be maintained, particularly regarding bone and neurological risks.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 67-75"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women 减肥手术后n端前b型利钠肽增加与胰岛素抵抗降低有关,在女性中更为明显。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.09.011
Flora I. Kartnig M.D. , Marlene Prager M.D. , Carsten T. Herz M.D. , Oana C. Kulterer M.D., Ph.D. , Elaine M. Khoshmehr , Rita Horodecki-Tucheslau M.D. , Michael R. Krebs M.D. , Gerhard Prager M.D. , Alexandra Kautzky-Willer M.D. , Florian W. Kiefer M.D., Ph.D.

Background

Obesity is linked to increased risk of cardiovascular disease, type 2 diabetes, and overall mortality. Bariatric surgery effectively achieves long-term weight loss, especially in clinically severe obesity. Postoperative weight loss is associated with increased N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, without signs of cardiac dysfunction.

Objectives

We investigated longitudinal changes in NT-proBNP levels following different bariatric procedures and examined their associations with metabolic alterations.

Setting

This retrospective study was conducted in a large university hospital in central Europe using data from 2005 to 2016.

Methods

We analyzed preoperative and postoperative laboratory results from 508 patients undergoing three different bariatric procedures. Follow-up records were available for 347 (68.3%) patients at month 3, 260 (51.2%) at month 6, 152 (29.9%) at month 9, 183 (36.0%) at month 12, 166 (32.7%) at month 18, and 127 (25.0%) at month 24 postsurgery.

Results

NT-proBNP levels rose shortly after bariatric surgery and remained elevated, with no significant differences between surgical types. Women exhibited significantly higher postoperative NT-proBNP concentrations than men. The increase in NT-proBNP correlated with improved insulin resistance but not with other metabolic parameters. We found no evidence supporting reduced renal clearance as a cause for elevated natriuretic peptides.

Conclusions

Our data suggest a link between the NT-proBNP increase and reduced hyperinsulinemia following bariatric surgery, offering new insights into mechanisms underlying this frequent postoperative finding.
背景:肥胖与心血管疾病、2型糖尿病和总死亡率增加有关。减肥手术能有效实现长期减肥,尤其是临床重度肥胖患者。术后体重减轻与n端前b型利钠肽(NT-proBNP)水平升高相关,无心功能障碍迹象。目的:我们研究了不同减肥过程后NT-proBNP水平的纵向变化,并研究了它们与代谢改变的关系。背景:本回顾性研究在中欧一家大型大学医院进行,使用2005年至2016年的数据。方法:我们分析了508例接受三种不同减肥手术的患者的术前和术后实验室结果。术后第3个月随访347例(68.3%),第6个月随访260例(51.2%),第9个月随访152例(29.9%),第12个月随访183例(36.0%),第18个月随访166例(32.7%),第24个月随访127例(25.0%)。结果:NT-proBNP水平在减肥手术后不久上升并保持升高,手术类型之间无显著差异。术后女性NT-proBNP浓度明显高于男性。NT-proBNP的增加与胰岛素抵抗的改善相关,但与其他代谢参数无关。我们没有发现证据支持肾脏清除率降低是利钠肽升高的原因。结论:我们的数据表明,减肥手术后NT-proBNP增加和高胰岛素血症降低之间存在联系,为这种常见的术后发现的机制提供了新的见解。
{"title":"N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women","authors":"Flora I. Kartnig M.D. ,&nbsp;Marlene Prager M.D. ,&nbsp;Carsten T. Herz M.D. ,&nbsp;Oana C. Kulterer M.D., Ph.D. ,&nbsp;Elaine M. Khoshmehr ,&nbsp;Rita Horodecki-Tucheslau M.D. ,&nbsp;Michael R. Krebs M.D. ,&nbsp;Gerhard Prager M.D. ,&nbsp;Alexandra Kautzky-Willer M.D. ,&nbsp;Florian W. Kiefer M.D., Ph.D.","doi":"10.1016/j.soard.2025.09.011","DOIUrl":"10.1016/j.soard.2025.09.011","url":null,"abstract":"<div><h3>Background</h3><div>Obesity is linked to increased risk of cardiovascular disease, type 2 diabetes, and overall mortality. Bariatric surgery effectively achieves long-term weight loss, especially in clinically severe obesity. Postoperative weight loss is associated with increased N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, without signs of cardiac dysfunction.</div></div><div><h3>Objectives</h3><div>We investigated longitudinal changes in NT-proBNP levels following different bariatric procedures and examined their associations with metabolic alterations.</div></div><div><h3>Setting</h3><div>This retrospective study was conducted in a large university hospital in central Europe using data from 2005 to 2016.</div></div><div><h3>Methods</h3><div>We analyzed preoperative and postoperative laboratory results from 508 patients undergoing three different bariatric procedures. Follow-up records were available for 347 (68.3%) patients at month 3, 260 (51.2%) at month 6, 152 (29.9%) at month 9, 183 (36.0%) at month 12, 166 (32.7%) at month 18, and 127 (25.0%) at month 24 postsurgery.</div></div><div><h3>Results</h3><div>NT-proBNP levels rose shortly after bariatric surgery and remained elevated, with no significant differences between surgical types. Women exhibited significantly higher postoperative NT-proBNP concentrations than men. The increase in NT-proBNP correlated with improved insulin resistance but not with other metabolic parameters. We found no evidence supporting reduced renal clearance as a cause for elevated natriuretic peptides.</div></div><div><h3>Conclusions</h3><div>Our data suggest a link between the NT-proBNP increase and reduced hyperinsulinemia following bariatric surgery, offering new insights into mechanisms underlying this frequent postoperative finding.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 106-112"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement in breathlessness following bariatric surgery as measured by a new heart failure–specific health-related quality of life instrument: a prospective longitudinal study 通过一种新的心力衰竭特异性健康相关生活质量仪器测量的减肥手术后呼吸困难的改善:一项前瞻性纵向研究
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.09.014
Hila Zelicha R.D., Ph.D. , Zachary N. Weitzner M.D. , Seuna Park N.P. , Tony G. Babb Ph.D. , Vipa Bernhardt Ph.D. , Faraz S. Ahmad M.D., M.S. , David Cella Ph.D. , Yijun Chen M.D. , Edward H. Livingston M.D.

Background

There is a need for an instrument that efficiently identifies heart failure (HF) symptoms in patients with obesity.

Objectives

To determine the spectrum of HF symptoms in patients with severe obesity who lose weight following bariatric surgery using a new, validated HF health-related quality of life (HRQOL) instrument, Patient-Reported Outcomes Measurement Information System (PROMIS) + HF-27.

Setting

Health academic quaternary care center in the United States.

Methods

Prospective longitudinal 12-month cohort study. PROMIS + HF-27 HRQOL surveys were administered before and 1 year after sleeve gastrectomy. T-scores anchoring HRQOL domain scores to the U.S. general population were calculated. Dyspnea T-scores were centered on a chronic obstructive pulmonary disease reference population.

Results

Of 40 patients at baseline, 33 (83%) reported some degree of dyspnea: mild n = 18 (55%), moderate n = 12 (36%), and severe n = 3 (9%) on the PROMIS + HF-27 survey. Only 1 patient had been given a clinical diagnosis of dyspnea during routine primary care visits. Dyspnea, physical function, fatigue, sleep disorders, and pain T-scores were significantly improved (dyspnea: preoperative: 45.3 ± 8.2, postoperative: 35.6 ± 4.9, P < .0001; physical function: preoperative: 47.7 ± 7.6, postoperative: 52.3 ± 5.3, P = .001; fatigue: preoperative: 54.5 ± 8.6, postoperative: 45.7 ± 8.1, P < .000; sleep disorders: preoperative: 52.1 ± 8.5, postoperative: 46.6 ± 7.8, P = .002; pain: preoperative: 55.1 ± 9.4, postoperative: 47.3 ± 6.2, P < .0001; n = 40). Depression and cognitive disturbances T-scores did not significantly change after surgery (P > .05 for all). Summary scores for physical function, social roles, mental function, and the overall HRQOL total score were significantly improved 1 year after bariatric surgery (P < .05). None of the summary scores or the domain T-scores, including dyspnea, were significantly associated with weight loss adjusted for sex, age, and preoperative weight.

Conclusions

PROMIS + HF-27 efficiently measured and detected improvements in multiple obesity-relevant HRQOL domains following sleeve gastrectomy. Of these, dyspnea was the most prominent and showed the largest improvement after bariatric surgery.
背景:需要一种能有效识别肥胖患者心力衰竭(HF)症状的仪器。目的:利用一种新的、经过验证的HF健康相关生活质量(HRQOL)仪器——患者报告的结局测量信息系统(PROMIS) + HF-27,确定在减肥手术后体重减轻的严重肥胖患者的HF症状谱。背景:美国卫生学术四级保健中心。方法:前瞻性纵向12个月队列研究。在袖式胃切除术前和术后1年进行PROMIS + HF-27 HRQOL调查。计算将HRQOL领域分数锚定到美国一般人群的t分数。呼吸困难t评分集中于慢性阻塞性肺疾病参考人群。结果:在40例基线患者中,33例(83%)报告了一定程度的呼吸困难:PROMIS + HF-27调查中,轻度n = 18(55%),中度n = 12(36%),重度n = 3(9%)。在常规的初级保健访问中,只有1例患者被诊断为呼吸困难。呼吸困难、身体功能、疲劳、睡眠障碍和疼痛t指数显著提高(术后:呼吸困难:术前:45.3±8.2,35.6±4.9,P <。;物理性能:术前:47.7±7.6,术后:52.3±5.3,P =措施;疲劳:术前:54.5±8.6,术后:45.7±8.1,P <组织;睡眠障碍:术前:52.1±8.5,术后:46.6±7.8,P = .002;疼痛:术前:55.1±9.4,术后:47.3±6.2,P <。;n = 40)。术后抑郁和认知障碍t评分无显著变化(P < 0.05)。减肥手术后1年身体功能、社会角色、心理功能综合评分及HRQOL总评分均有显著提高(P < 0.05)。包括呼吸困难在内的总结评分和区域t评分与经性别、年龄和术前体重调整后的体重减轻均无显著相关性。结论:PROMIS + HF-27有效地测量和检测了袖胃切除术后多个肥胖相关HRQOL域的改善。其中,呼吸困难最为突出,在减肥手术后改善最大。
{"title":"Improvement in breathlessness following bariatric surgery as measured by a new heart failure–specific health-related quality of life instrument: a prospective longitudinal study","authors":"Hila Zelicha R.D., Ph.D. ,&nbsp;Zachary N. Weitzner M.D. ,&nbsp;Seuna Park N.P. ,&nbsp;Tony G. Babb Ph.D. ,&nbsp;Vipa Bernhardt Ph.D. ,&nbsp;Faraz S. Ahmad M.D., M.S. ,&nbsp;David Cella Ph.D. ,&nbsp;Yijun Chen M.D. ,&nbsp;Edward H. Livingston M.D.","doi":"10.1016/j.soard.2025.09.014","DOIUrl":"10.1016/j.soard.2025.09.014","url":null,"abstract":"<div><h3>Background</h3><div>There is a need for an instrument that efficiently identifies heart failure (HF) symptoms in patients with obesity.</div></div><div><h3>Objectives</h3><div>To determine the spectrum of HF symptoms in patients with severe obesity who lose weight following bariatric surgery using a new, validated HF health-related quality of life (HRQOL) instrument, Patient-Reported Outcomes Measurement Information System (PROMIS) + HF-27.</div></div><div><h3>Setting</h3><div>Health academic quaternary care center in the United States.</div></div><div><h3>Methods</h3><div>Prospective longitudinal 12-month cohort study. PROMIS + HF-27 HRQOL surveys were administered before and 1 year after sleeve gastrectomy. T-scores anchoring HRQOL domain scores to the U.S. general population were calculated. Dyspnea T-scores were centered on a chronic obstructive pulmonary disease reference population.</div></div><div><h3>Results</h3><div>Of 40 patients at baseline, 33 (83%) reported some degree of dyspnea: mild n = 18 (55%), moderate n = 12 (36%), and severe n = 3 (9%) on the PROMIS + HF-27 survey. Only 1 patient had been given a clinical diagnosis of dyspnea during routine primary care visits. Dyspnea, physical function, fatigue, sleep disorders, and pain T-scores were significantly improved (dyspnea: preoperative: 45.3 ± 8.2, postoperative: 35.6 ± 4.9, <em>P</em> &lt; .0001; physical function: preoperative: 47.7 ± 7.6, postoperative: 52.3 ± 5.3, <em>P</em> = .001; fatigue: preoperative: 54.5 ± 8.6, postoperative: 45.7 ± 8.1, <em>P</em> &lt; .000; sleep disorders: preoperative: 52.1 ± 8.5, postoperative: 46.6 ± 7.8, <em>P</em> = .002; pain: preoperative: 55.1 ± 9.4, postoperative: 47.3 ± 6.2, <em>P</em> &lt; .0001; n = 40). Depression and cognitive disturbances T-scores did not significantly change after surgery (<em>P</em> &gt; .05 for all). Summary scores for physical function, social roles, mental function, and the overall HRQOL total score were significantly improved 1 year after bariatric surgery (<em>P</em> &lt; .05). None of the summary scores or the domain T-scores, including dyspnea, were significantly associated with weight loss adjusted for sex, age, and preoperative weight.</div></div><div><h3>Conclusions</h3><div>PROMIS + HF-27 efficiently measured and detected improvements in multiple obesity-relevant HRQOL domains following sleeve gastrectomy. Of these, dyspnea was the most prominent and showed the largest improvement after bariatric surgery.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 137-144"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145531046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: “Effects of neoadjuvant glucagon-like-peptide 1 receptor agonists on weight loss after bariatric surgery” 评论:“新辅助胰高血糖素样肽1受体激动剂对减肥手术后体重减轻的影响”。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.11.001
Sean M. O’Neill M.D., Ph.D., Ryan A. Howard M.D., Hope T. Jackson M.D.
{"title":"Comment on: “Effects of neoadjuvant glucagon-like-peptide 1 receptor agonists on weight loss after bariatric surgery”","authors":"Sean M. O’Neill M.D., Ph.D.,&nbsp;Ryan A. Howard M.D.,&nbsp;Hope T. Jackson M.D.","doi":"10.1016/j.soard.2025.11.001","DOIUrl":"10.1016/j.soard.2025.11.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 24-25"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoglycemia following metabolic and bariatric surgery: evidence from objective and subjective naturalistic assessment methods 代谢和减肥手术后的低血糖:来自客观和主观自然评估方法的证据。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.07.015
Gail A. Kerver Ph.D. , Kristine J. Steffen Pharm.D., Ph.D. , Glen Forester Ph.D. , Leslie A. Laam Ph.D. , Sugong Chen M.D. , Ellen Vogels D.O. , David B. Sarwer Ph.D. , Stephen A. Wonderlich Ph.D. , Scott G. Engel Ph.D.

Background

Hypoglycemia (i.e., low blood glucose) is a potential complication following metabolic and bariatric surgery (MBS) that can ultimately result in severe and deadly consequences. However, the symptoms typically associated with hypoglycemia (e.g., dizziness, anxiety) can be nonspecific, which impairs effective monitoring.

Objectives

This study utilized a unique combination of naturalistic assessments to compare the subjective self-report of hypoglycemic symptoms measured via ecological momentary assessment (EMA) with objectively-collected data from continuous glucose monitoring (CGM).

Setting

Private Hospital, United States.

Methods

Participants were 44 adults who completed 10 days of EMA and CGM 1 year after undergoing Roux-en-Y gastric bypass. Multiple times per day during the EMA protocol, participants identified how many of 18 hypoglycemic symptoms they had experienced since they were last signaled several hours earlier.

Results

CGM data showed that ∼66% of participants experienced at least one possible daytime hypoglycemic event (range = 1-23 episodes/person). The total number of hypoglycemic symptoms endorsed via EMA did not correspond with the occurrence of a possible hypoglycemic event captured by CGM (P = .145). However, multilevel models revealed that participants were more likely to report feeling “shaky”, “lightheaded”, and “coordination problems/clumsiness” (false discovery rate corrected P values < .05) during periods of time coinciding with possible hypoglycemic events identified by CGM.

Conclusions

Many patients are at risk for low blood glucose post-MBS. In the absence of objective assessment, several subjective symptoms may serve as indicators of possible hypoglycemic events following MBS.
背景:低血糖(即低血糖)是代谢和减肥手术(MBS)后的潜在并发症,最终可能导致严重和致命的后果。然而,与低血糖相关的典型症状(如头晕、焦虑)可能是非特异性的,从而影响有效监测。目的:本研究采用自然评估的独特组合,比较通过生态瞬时评估(EMA)测量的低血糖症状的主观自我报告与通过连续血糖监测(CGM)收集的客观数据。地点:美国私立医院。方法:参与者为44名成年人,他们在Roux-en-Y胃旁路手术1年后完成了10天的EMA和CGM。在EMA方案中,参与者每天多次确定自几小时前最后一次信号发出以来,他们经历了18种低血糖症状中的多少种。结果:CGM数据显示,约66%的参与者至少经历了一次可能的白天低血糖事件(范围= 1-23次/人)。EMA认可的低血糖症状总数与CGM捕获的可能低血糖事件的发生不一致(P = 0.145)。然而,多层模型显示,在与CGM识别的可能的低血糖事件相吻合的时间段内,参与者更有可能报告感觉“颤抖”、“头晕”和“协调问题/笨拙”(错误发现率校正P值< 0.05)。结论:许多患者在mbs后存在低血糖风险。在缺乏客观评估的情况下,一些主观症状可以作为MBS后可能发生低血糖事件的指标。
{"title":"Hypoglycemia following metabolic and bariatric surgery: evidence from objective and subjective naturalistic assessment methods","authors":"Gail A. Kerver Ph.D. ,&nbsp;Kristine J. Steffen Pharm.D., Ph.D. ,&nbsp;Glen Forester Ph.D. ,&nbsp;Leslie A. Laam Ph.D. ,&nbsp;Sugong Chen M.D. ,&nbsp;Ellen Vogels D.O. ,&nbsp;David B. Sarwer Ph.D. ,&nbsp;Stephen A. Wonderlich Ph.D. ,&nbsp;Scott G. Engel Ph.D.","doi":"10.1016/j.soard.2025.07.015","DOIUrl":"10.1016/j.soard.2025.07.015","url":null,"abstract":"<div><h3>Background</h3><div>Hypoglycemia (i.e., low blood glucose) is a potential complication following metabolic and bariatric surgery (MBS) that can ultimately result in severe and deadly consequences. However, the symptoms typically associated with hypoglycemia (e.g., dizziness, anxiety) can be nonspecific, which impairs effective monitoring.</div></div><div><h3>Objectives</h3><div>This study utilized a unique combination of naturalistic assessments to compare the subjective self-report of hypoglycemic symptoms measured via ecological momentary assessment (EMA) with objectively-collected data from continuous glucose monitoring (CGM).</div></div><div><h3>Setting</h3><div>Private Hospital, United States.</div></div><div><h3>Methods</h3><div>Participants were 44 adults who completed 10 days of EMA and CGM 1 year after undergoing Roux-en-Y gastric bypass. Multiple times per day during the EMA protocol, participants identified how many of 18 hypoglycemic symptoms they had experienced since they were last signaled several hours earlier.</div></div><div><h3>Results</h3><div>CGM data showed that ∼66% of participants experienced at least one possible daytime hypoglycemic event (range = 1-23 episodes/person). The total number of hypoglycemic symptoms endorsed via EMA did not correspond with the occurrence of a possible hypoglycemic event captured by CGM (<em>P</em> = .145). However, multilevel models revealed that participants were more likely to report feeling “shaky”, “lightheaded”, and “coordination problems/clumsiness” (false discovery rate corrected <em>P</em> values &lt; .05) during periods of time coinciding with possible hypoglycemic events identified by CGM.</div></div><div><h3>Conclusions</h3><div>Many patients are at risk for low blood glucose post-MBS. In the absence of objective assessment, several subjective symptoms may serve as indicators of possible hypoglycemic events following MBS.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 157-163"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Will metabolic bariatric surgery improve my patient’s mood? A careful examination of the relationship between mood, negative affect, and weight loss and recurrence after surgery 代谢减肥手术能改善病人的情绪吗?仔细检查情绪、负面影响、体重减轻和术后复发之间的关系。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.08.026
Scott G. Engel Ph.D. , Stephen A. Wonderlich Ph.D. , Debra Safer M.D. , Gail A. Kerver Ph.D. , Leslie A. Laam Ph.D. , Ross D. Crosby Ph.D. , Katherine Nameth B.S. , Leslie J. Heinberg Ph.D. , Dale Bond Ph.D. , Kristine J. Steffen Pharm.D., Ph.D.

Background

There is considerable variability in both the timing of weight change and changes in psychological difficulties functioning following metabolic bariatric surgery (MBS). Empirical studies appear to show that levels of depressive symptoms decrease with weight loss and increase due to weight recurrence. Yet, this research has not included sufficient repeated measurements to account for individual differences in the timing of when weight nadir is achieved and weight recurrence begins post-MBS.

Objectives

Examine how trait-like measures of mood and momentary measures of affect change over time relative to when an individual reach their nadir weight following MBS.

Setting

A health care facility in Sanford Research, Fargo, ND and a university health care facility in Stanford University, Stanford, CA.

Methods

Participants provided data from before surgery until 3 years after surgery. Depressive symptoms (as measured by the Beck Depressive symptoms Inventory) and weight were collected during in-person visits at 6-, 12-, 15-, 18-, 21-, 24-, 30-, and 36-months postsurgery. Momentary mood was assessed via ecologic momentary assessment at 1, 2, and 3 years after surgery.

Results

No difference in BDI scores emerged relative to weight nadir (both before and after nadir). However, there was a statistically-significant positive association between time in months relative to weight nadir and momentary negative affect, but this effect was quite small.

Conclusions

The current study suggests that depressive symptoms does not improve in the time between MBS and weight nadir (i.e., weight loss phase) and also does not deteriorate meaningfully after patients reach their weight nadir (i.e., weight recurrence phase). While momentary negative affect was related to weight change after surgery, this small effect is not likely clinically meaningful.
背景:代谢减肥手术(MBS)后体重变化的时间和心理困难功能的变化都有相当大的可变性。实证研究似乎表明,抑郁症状的水平随着体重减轻而降低,而由于体重复发而增加。然而,这项研究并没有包括足够的重复测量来解释mbs后体重最低点达到和体重复发时间的个体差异。目的:研究情绪的特征测量和情感的瞬间测量是如何随着时间的推移而变化的,相对于个体在MBS后达到最低点的时候。环境:一所位于北达科他州法戈市桑福德研究所的卫生保健机构和一所位于加州斯坦福大学的大学卫生保健机构。方法:参与者提供从术前到术后3年的数据。在术后6个月、12个月、15个月、18个月、21个月、24个月、30个月和36个月的亲自访问中收集抑郁症状(通过贝克抑郁症状量表测量)和体重。术后1年、2年和3年通过生态瞬时评估评估瞬时情绪。结果:BDI评分相对于体重最低点(最低点前后)均无差异。然而,相对于体重最低点的月数与短暂的负面情绪之间存在统计学上显著的正相关,但这种影响相当小。结论:本研究提示,在MBS和体重最低点(即体重减轻期)之间的时间内,抑郁症状没有改善,在患者达到体重最低点(即体重复发期)后,抑郁症状也没有明显恶化。虽然短暂的负面影响与术后体重变化有关,但这种小影响可能没有临床意义。
{"title":"Will metabolic bariatric surgery improve my patient’s mood? A careful examination of the relationship between mood, negative affect, and weight loss and recurrence after surgery","authors":"Scott G. Engel Ph.D. ,&nbsp;Stephen A. Wonderlich Ph.D. ,&nbsp;Debra Safer M.D. ,&nbsp;Gail A. Kerver Ph.D. ,&nbsp;Leslie A. Laam Ph.D. ,&nbsp;Ross D. Crosby Ph.D. ,&nbsp;Katherine Nameth B.S. ,&nbsp;Leslie J. Heinberg Ph.D. ,&nbsp;Dale Bond Ph.D. ,&nbsp;Kristine J. Steffen Pharm.D., Ph.D.","doi":"10.1016/j.soard.2025.08.026","DOIUrl":"10.1016/j.soard.2025.08.026","url":null,"abstract":"<div><h3>Background</h3><div>There is considerable variability in both the timing of weight change and changes in psychological difficulties functioning following metabolic bariatric surgery (MBS). Empirical studies appear to show that levels of depressive symptoms decrease with weight loss and increase due to weight recurrence. Yet, this research has not included sufficient repeated measurements to account for individual differences in the timing of when weight nadir is achieved and weight recurrence begins post-MBS.</div></div><div><h3>Objectives</h3><div>Examine how trait-like measures of mood and momentary measures of affect change over time relative to when an individual reach their nadir weight following MBS.</div></div><div><h3>Setting</h3><div>A health care facility in Sanford Research, Fargo, ND and a university health care facility in Stanford University, Stanford, CA.</div></div><div><h3>Methods</h3><div>Participants provided data from before surgery until 3 years after surgery. Depressive symptoms (as measured by the Beck Depressive symptoms Inventory) and weight were collected during in-person visits at 6-, 12-, 15-, 18-, 21-, 24-, 30-, and 36-months postsurgery. Momentary mood was assessed via ecologic momentary assessment at 1, 2, and 3 years after surgery.</div></div><div><h3>Results</h3><div>No difference in BDI scores emerged relative to weight nadir (both before and after nadir). However, there was a statistically-significant positive association between time in months relative to weight nadir and momentary negative affect, but this effect was quite small.</div></div><div><h3>Conclusions</h3><div>The current study suggests that depressive symptoms does not improve in the time between MBS and weight nadir (i.e., weight loss phase) and also does not deteriorate meaningfully after patients reach their weight nadir (i.e., weight recurrence phase). While momentary negative affect was related to weight change after surgery, this small effect is not likely clinically meaningful.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 145-150"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145461039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “unveiling the cost-effectiveness of bariatric surgery: insights from a matched cohort study” 对“揭示减肥手术的成本效益:来自匹配队列研究的见解”发表评论。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.08.018
Gita Venkata Siva Maruthi Alluri, Koyel Roy, Sunil
{"title":"Comment on “unveiling the cost-effectiveness of bariatric surgery: insights from a matched cohort study”","authors":"Gita Venkata Siva Maruthi Alluri,&nbsp;Koyel Roy,&nbsp;Sunil","doi":"10.1016/j.soard.2025.08.018","DOIUrl":"10.1016/j.soard.2025.08.018","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 181-182"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145484425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: “Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy” 评论:“利用腔内真空治疗实现袖式胃切除术患者渗漏的最佳营养目标”。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.11.005
Mélissa V. Wills M.D., Matthew Kroh M.D.
{"title":"Comment on: “Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy”","authors":"Mélissa V. Wills M.D.,&nbsp;Matthew Kroh M.D.","doi":"10.1016/j.soard.2025.11.005","DOIUrl":"10.1016/j.soard.2025.11.005","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 46-48"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery for Obesity and Related Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1